11th Swiss Pharma Science Day 2018 – „Cancer“

This year’s Swiss Pharma Science Day is focused on Cancer with the following presentations:

 

«National Strategy Against Cancer»

Dr. sc.nat. Michael Röthlisberger,  Nationale Strategie gegen Krebs, Krebsliga, Bern

 

«Non-biological Complex Nanomedicines and Their Preclinical Evaluation»

Dr. Scott McNeil, NCL-NCI Frederick MD, U.S.A.

 

«Lessons to be Learned: The Molecular Basis of Kinase-Targeted Therapies and Drug Resistance in Non-Small Cell Lung Cancer»

Prof. Dr. Daniel Rauh, TU Dortmund

 

«Development of Oral LFA-1 Inhibitors»

Prof. Dr. pharm. et med. Stephan Krähenbühl, University Hospital & University of Basel

 

«Nonadherence to Oral Targeted Anticancer Drugs: What’s the Problem and How to Address It ?»

Dr. Marie-Paule Schneider, Policlinique MédicaleUniversitaire and EPGL University of Geneva

 

More Information & Registration & Poster Session

 

If you like to Sponsor the Event, please get in touch via Email to [email protected]

Download

11th Swiss Pharma Science Day – Program
sphsd 2018_program_final.pdf
Adobe Acrobat Document 332.2 KB
Download

11th Swiss Pharma Science Day- Poster Information
sphsd 2018_poster.pdf
Adobe Acrobat Document 39.7 KB

You might also like
11th-swiss-pharma-science-day-2018-quot-cancer-quot-pharma-excipients